SA
AVNS

Nasdaq, Russell 2000 below the 200-day average · S&P 500 below the 50-day average (VIX 22.6)

Overview →
11/19/26

Avanos Medical (AVNS)

Thursday
9:46 AM ET
ThesisAvanos Medical: the story is balanced — Hospital procedure volume trends - elective surgery rates, ICU census levels…

Revenue Outlook

★ Analysts see FY2027 revenue reaching $740M — +4.2% growth in a single year.

What Moves the Stock

  1. 01Hospital procedure volume trends - elective surgery rates, ICU census levels, and enteral feeding patient admissions directly drive consumable device utilization
  2. 02GPO contract wins/losses and pricing negotiations - major hospital group purchasing organization contracts determine market access and pricing for 2-3 year periods
  3. 03Gross margin trajectory - ability to offset input cost inflation through manufacturing efficiency, product mix shift toward higher-margin pain management products
  4. 04Operating expense management and restructuring progress - given negative net margin, investors focus on path to sustainable profitability and cash generation
  5. 05New product launches and clinical trial data - FDA approvals for next-generation devices or clinical studies demonstrating superior outcomes versus competitors
  6. 06Chronic Care segment (~60-65% estimated): enteral feeding devices, gastrostomy tubes, securement products for long-term patient care
  7. 07Pain Management segment (~20-25% estimated): ON-Q continuous nerve block systems, surgical site infiltration catheters for post-operative pain control
  8. 08Respiratory Health segment (~10-15% estimated): closed suction systems, airway management devices for ICU and ventilated patients
FY2025 Snapshot
Revenue
$701M
NI Growth
+82.7%
EPS
$-1.46

AVNS Chart

11.515.118.822.526.224.99AVNS Daily24.99Mar '26Apr '26Jun '26Jul '26

My Notes

  • value/special situations - The 0.9x price/book ratio, 1.0x price/sales, and 11.7% FCF yield suggest deep value investors…
  • Rising interest rates have modest negative impact through two channels: (1) higher borrowing costs on any variable-rate debt or refinancing…
  • Watch on earnings: US hospital admissions and surgical procedure volumes - leading indicator of device utilization across all segments, Medical device PPI (Producer Price Index) - tracks input cost inflation for plastics, resins, and components affecting gross margins, Medicare reimbursement rate changes - affects hospital budgets and willingness to purchase premium-priced devices.

One Sentence Summary:

Avanos Medical: the story is balanced — hospital procedure volume trends - elective surgery rates, icu census levels, and enteral feeding patient admissions directly drive.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.